Pervasip Corp.

Pervasip Corp.

PVSP
Pervasip Corp.US flagOther OTC
0.00
USD
+0.00
- -
755,602.00Market Cap
Pervasip Corp.
PVSP
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
TTM
FRC
9.01
13.21
9.13
3.55
5.88
9.47
0.13
0.43
0.81
0.83
0.42
0.03
0.01
- -
- -
- -
- -
Revenue per Share
-4.07
-8.3
-2.13
5.3
0.1
-1.35
-1.35
-1.28
-2.08
-1.86
-1
-0.1
0.02
- -
- -
- -
- -
Basic EPS, GAAP
-5.09
-2.3
1.76
-1.04
-0.16
-1.27
-1.02
-1.02
-1.34
-0.54
-0.14
-0.01
-0.01
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-15.36
-21.85
-22.99
-17.5
-16.81
-17.61
-18.06
-14.52
-15.17
-17.33
-14.76
-1.24
-0.31
-0.08
-0.05
-0.02
-0.01
Book Value per Share
3.95
-4.44
-6.51
-1.19
-1.04
-1.41
-2.45
-2.64
-4.19
-5.77
-5.22
-0.43
-0.07
-0.02
-0.01
- -
- -
Tangible Book Value per Share
1
1
2
2
2
2
2
2
3
3
3
44
166
633
980
3,079
3,732
Basic Weighted Avg Shares
12
20
14
6
10
16
- -
1
2
2
1
1
1
1
- -
1
1
Sales/Revenue/Turnover
-55.43
-63.99
-31.46
-51.7
-14.49
-15.12
-1,353.62
-387.37
-199.16
-133.98
-129.76
-123.86
-154.77
-135.52
-173.12
-103.37
-188.76
Operating Margin (%)
1
1
- -
- -
- -
1
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-5
-12
-3
8
- -
-2
-2
-3
-5
-5
-3
-4
3
- -
- -
- -
-1
Net Income, GAAP
- -
- -
- -
0.89
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-45.18
-62.83
-23.31
149.48
1.78
-14.27
-1,052.84
-299.52
-257.06
-223.61
-235.62
-344.47
300.2
48.47
-93.38
80.29
-142.16
Profit Margin (%)
2
-8
-11
-2
-2
-1
-5
-1
-1
-14
-16
-19
-12
-9
-9
-9
-10
Working Capital
2
1
1
- -
- -
2
- -
2
4
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
9
-7
-10
-2
-2
-2
-4
-6
-11
-16
-18
-19
-12
-11
-9
-9
-10
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
-26.93
- -
- -
- -
- -
- -
- -
- -
- -
-12.35
-8.01
- -
-4.52
-4.31
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Feb'16
May'16
Aug'16
ST Debt
4
4
4
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,652
3,778
3,778
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Feb'16
May'16
Aug'16
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
9
9
10
Payables & Accruals
4
5
5
ST Debt
4
4
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.17%
-11.4%
-3.17%
Free Cash Flow
5.47%
23.19%
123.24%
Net Income, GAAP
-55.93%
-126.27%
-205.87%
Sales/Revenue/Turnover
26.62%
-12.98%
23.13%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
No data availableFinancial data will appear here once available
Business
Pervasip Corp. (PVSP) develops companies and technologies in high-value emerging markets, with a primary focus on industrial agriculture, including cloud-based applications to monitor and control greenhouse facilities; cannabinoid analysis methods for flowers, concentrates, and edibles; and products supporting medical marijuana production for dosage regulation and consistency. The company offers technologies and investments in cannabis operations through its wholly owned subsidiary Artizen Corp. and Zen Asset Management LLC (ZAM), which manages diversified cannabis assets covering flower, pre-rolls, dabbable concentrates, vapes, and nano-emulsified tinctures under brands such as Artizen, Slurped, Emerald City Cultivation, Emerald City Cured, Dabco, Dabs4Less, and Vapes4Less; it also targets medical fungi and psychedelics sectors. Founded in 1964 and headquartered in White Plains, New York, Pervasip operates principally in the United States, serving agricultural markets, cannabis producers/processors, and wellness industries. Recent developments include the 2022 strategic acquisition of BCCTG assets, adding brands and a Tier 2 producer/processor license while projecting up to $12 million in additional concentrates revenue through integration with Artizen; the 2023 purchase of the Slurped nano tincture brand and launch of Artizen Nano to enter the $8 billion global nano-emulsification market for enhanced bioavailability in cannabis and non-cannabis wellness products; and the August 2025 announcement of a corporate restructuring to spin out a new subsidiary as a standalone public entity, aligning with prior growth roadmaps in emerging markets.

Company News

APIChat